i
Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023
-
6 2024
-
-
Source: Emerg Infect Dis. 2024; 30(6):1267-1270
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall seroprevalence of 45.3% for nucleocapsid antibodies and 95.4% for spike antibodies and found notable maternally derived spike antibodies in infants 6-11 months of age (90.0%).
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:38782366
-
Pubmed Central ID:PMC11138984
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: